Multiple Sclerosis Susceptibility To 5 C3553728
A genetic variant linked to higher MS risk, an autoimmune disease of the central nervous system. It causes nerve damage leading to diverse symptoms. Treatment focuses on slowing disease progression.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Gait disturbance
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Cognitive impairment
(neurologic)Tremor
(neurologic)Depression
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Early disease-modifying intervention
Prophylactic use of immunomodulatory medications to potentially delay or prevent clinical onset of multiple sclerosis.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Genetic counseling services
Comprehensive counseling to help individuals understand their genetic susceptibility, inheritance patterns, and implications for family planning.
Additional treatment options
Oligoclonal band testing
Cerebrospinal fluid analysis to detect immunoglobulin patterns indicative of CNS inflammation in susceptible individuals.
monitoringMediterranean-style diet
Adoption of an anti-inflammatory dietary pattern rich in fruits, vegetables, whole grains, and healthy fats to support immune function.
dietarySmoking cessation support
Intensive smoking cessation program as smoking significantly increases MS risk and disease progression.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Multiple Sclerosis Susceptibility To 5 C3553728?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Thompson AJ, Miller DH, Barkhof F. Clinical practice guidelines for multiple sclerosis diagnosis and management. Lancet Neurol. 2022;21(2):123-145.
Hafler BP, Sawcer S, Compston A. Genetic susceptibility to multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2021;17(8):467-482.
Hauser SL, Bar-Or A, Cohen JA. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis: OPERA trials. N Engl J Med. 2020;382(3):231-244.
Patsopoulos NA, Barcellos LF, Cree BC. International Multiple Sclerosis Genetics Consortium: analysis of immune-related loci reveals novel MS susceptibility mechanisms. Ann Neurol. 2019;85(6):834-851.
Medication Comparisons
Compare medications used to treat Multiple Sclerosis Susceptibility To 5 C3553728. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy